CliniSys Acquires ApolloLIMS To Grow Community and Public Health Diagnostics Capability

Acquisition confirms CliniSys Group as a market leader in public health and toxicology diagnostics in North America and provides springboard for global growth.

CliniSys has acquired ApolloLIMS, a leading provider of laboratory information management systems based in Nashville, Tennessee, and with specialist expertise in clinical, public health, toxicology and molecular diagnostics.

The ApolloLIMS team will join CliniSys, bringing their industry expertise, knowledge and proven technology offering. The announcement confirms a significant step toward fulfilling CliniSys’ vision to enable a new wave of digital diagnostics and community laboratories, spanning Environmental, Water Quality, Public Health, Toxicology and Agriculture laboratory testing markets.

“ApolloLIMS and its team bring tremendous expertise to CliniSys. Not only will they help expand our knowledge of diagnostics within and beyond the clinical laboratory, but they share our deep belief that the future of digital diagnostics lies in the cloud,” said CliniSys’ CEO Michael Simpson. “With the addition of ApolloLIMS, we are now poised to seize new opportunities to quickly expand our offerings in community and public health diagnostics, and to help better track and prevent disease.”

All current ApolloLIMS customers will continue to be supported as normal. Over time the ApolloLIMS solution will be integrated into the CliniSys product family as the business accelerates the roadmap for its next-generation SaaS product strategy.

“ApolloLIMS diverse expertise helps us push the boundaries of the diagnostics market and enable organizations and governments to better fight the spread of disease,” said Eric Dingfelder, SVP and General Manager, HORIZON and ApolloLIMS (CliniSys Group companies). “Modern laboratories need the very best technology platforms to streamline their workflows and improve disease monitoring. Joining CliniSys ensures ApolloLIMS’ customers of that future.”